396 related articles for article (PubMed ID: 26173479)
1. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.
Shibata S; Tada Y; Hau CS; Mitsui A; Kamata M; Asano Y; Sugaya M; Kadono T; Masamoto Y; Kurokawa M; Yamauchi T; Kubota N; Kadowaki T; Sato S
Nat Commun; 2015 Jul; 6():7687. PubMed ID: 26173479
[TBL] [Abstract][Full Text] [Related]
2. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
[TBL] [Abstract][Full Text] [Related]
3. Reduction of CD18 promotes expansion of inflammatory γδ T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.
Gatzka M; Hainzl A; Peters T; Singh K; Tasdogan A; Wlaschek M; Scharffetter-Kochanek K
J Immunol; 2013 Dec; 191(11):5477-88. PubMed ID: 24190659
[TBL] [Abstract][Full Text] [Related]
4. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
5. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.
Cai Y; Shen X; Ding C; Qi C; Li K; Li X; Jala VR; Zhang HG; Wang T; Zheng J; Yan J
Immunity; 2011 Oct; 35(4):596-610. PubMed ID: 21982596
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 Regulates Psoriasiform Dermatitis by Controlling Homeostasis of IL-17-Producing γδ T Cells.
Jaiswal AK; Sadasivam M; Archer NK; Miller RJ; Dillen CA; Ravipati A; Park PW; Chakravarti S; Miller LS; Hamad ARA
J Immunol; 2018 Sep; 201(6):1651-1661. PubMed ID: 30045969
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
10. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice.
Pantelyushin S; Haak S; Ingold B; Kulig P; Heppner FL; Navarini AA; Becher B
J Clin Invest; 2012 Jun; 122(6):2252-6. PubMed ID: 22546855
[TBL] [Abstract][Full Text] [Related]
11. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells.
Imai Y; Ayithan N; Wu X; Yuan Y; Wang L; Hwang ST
J Immunol; 2015 Jul; 195(2):421-5. PubMed ID: 26048148
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting Vγ4+ γδ T Cells.
Dhillon-LaBrooy A; Braband KL; Tantawy E; Rampoldi F; Kao YS; Boukhallouk F; Velasquez LN; Mamareli P; Silva L; Damasceno LEA; Weidenthaler-Barth B; Berod L; Almeida L; Sparwasser T
J Invest Dermatol; 2024 Apr; 144(4):844-854.e2. PubMed ID: 37832844
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin-derived pentapeptide ameliorates psoriasiform skin inflammation by suppressing IL-17 production in γδT cells.
Suh JH; Lee Y; Ohn J; Kim EJ; Kim TG; Jo SJ; Kim SJ; Chung JH
J Dermatol Sci; 2022 Apr; 106(1):45-52. PubMed ID: 35331618
[TBL] [Abstract][Full Text] [Related]
15. Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.
Onderdijk AJ; Hekking-Weijma IM; Florencia EF; Prens EP
Methods Mol Biol; 2017; 1559():75-81. PubMed ID: 28063038
[TBL] [Abstract][Full Text] [Related]
16.
Bezdek S; Leng L; Busch H; Mousavi S; Rades D; Dahlke M; Zillikens D; Bucala R; Sadik CD
Front Immunol; 2018; 9():2262. PubMed ID: 30333830
[TBL] [Abstract][Full Text] [Related]
17. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
[TBL] [Abstract][Full Text] [Related]
18. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
[TBL] [Abstract][Full Text] [Related]
19. Inflammation induces dermal Vγ4+ γδT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses.
Ramírez-Valle F; Gray EE; Cyster JG
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8046-51. PubMed ID: 26080440
[TBL] [Abstract][Full Text] [Related]
20. IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.
Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Newland D; Wang Y; Liu S; Miao Z; Dang T; Zhang P; Charo IF; Singh R; Schall TJ
J Immunol; 2017 Nov; 199(9):3129-3136. PubMed ID: 28972090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
